Futura Medical PLC
LSE:FUM

Watchlist Manager
Futura Medical PLC Logo
Futura Medical PLC
LSE:FUM
Watchlist
Price: 32 GBX 0.16% Market Closed
Market Cap: 97.2m GBX
Have any thoughts about
Futura Medical PLC?
Write Note

EV/EBIT
Enterprise Value to EBIT

-21
Current
-17.3
Median
16.8
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-21
=
Enterprise Value
87.9m GBX
/
EBIT
-4.2m GBP
All Countries
Close
Market Cap EV/EBIT
UK
Futura Medical PLC
LSE:FUM
95.7m GBP -21
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
743.6B USD 53.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 23
US
Johnson & Johnson
NYSE:JNJ
346B USD 14.8
US
Merck & Co Inc
NYSE:MRK
248.8B USD 12.4
CH
Roche Holding AG
SIX:ROG
199.5B CHF 11.6
UK
AstraZeneca PLC
LSE:AZN
161.6B GBP 253.9
CH
Novartis AG
SIX:NOVN
171.3B CHF 13.2
US
Pfizer Inc
NYSE:PFE
149.2B USD 15.8
EBIT Growth EV/EBIT to Growth
UK
Futura Medical PLC
LSE:FUM
Average EV/EBIT: 2 011.1
Negative Multiple: -21
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.3
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.8
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.4
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.9
131%
1.9
CH
Novartis AG
SIX:NOVN
13.2
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.8
68%
0.2

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
882.4
2-Years Forward
EV/EBIT
13.9
3-Years Forward
EV/EBIT
16.3

See Also

Discover More